iMeds.se

Salmeterol/Fluticasone Cipla

Document: Salmeterol_Fluticasone Cipla pressurised inhalation, suspension ENG PL change

Package leaflet: Information for the patient


Salmeterol/Fluticasone Cipla 25 micrograms /125 micrograms /dose pressurised inhalation, suspension


Salmeterol/Fluticasone Cipla 25 micrograms /250 micrograms /dose pressurised inhalation, suspension


Salmeterol/fluticasone propionate


Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

- This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if

their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.


What is in this leaflet


What Salmeterol/Fluticasone Cipla is and what it is used for

What you need to know before you use Salmeterol/Fluticasone Cipla

How to use Salmeterol/Fluticasone Cipla

Possible side effects

How to store Salmeterol/Fluticasone Cipla

Contents of the pack and other information


What Salmeterol/Fluticasone Cipla is and what it is used for


Salmeterol/Fluticasone Cipla contains two medicines, salmeterol and fluticasone propionate


The doctor has precribed this medicine to help prevent breathing problems such as asthma.

You must use Salmeterol/Fluticasone Cipla every day as directed by your doctor. This will make sure that it works properly in controlling your asthma.


Salmeterol/Fluticasone Cipla helps to stop breathlessness and wheeziness coming on. It does not work once you are breathless or wheezy. If that happens you need to use a fast acting ‘reliever’ medication, such as salbutamol.


What you need to know before you use Salmeterol/Fluticasone Cipla


Do not take Salmeterol/Fluticasone Cipla:

If you are allergic(hypersensitive) to salmeterol, fluicasone propionate or any of the other ingredients

of this medicine (listed in section 6).


Warnings and precautions

Talk to your doctor or pharmacist or nurse before using Salmeterol/Fluticasone Cipla. Your doctor will supervise your treatment more closely if you have medical conditions such as:

If you have ever had any of these conditions, tell your doctor before you use Salmeterol/Fluticasone Cipla

Other medicines and Salmeterol/Fluticasone Cipla

Tell your doctor or pharmacist if you are taking, have recently taken or might use any other medicines. This includes medicine for asthma or any medicines obtained without a prescription. This is because Salmeterol/Fluticasone Cipla may not be suitable to be taken with some other medicines.


Tell your doctorif you are taking the following medicines, before starting to use Salmeterol/Fluticasone Cipla


Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planing to have a baby, ask your doctor for advice before taking this medicine.


Driving and using machines

Salmeterol/Fluticasone Cipla is not likely to affect your ability to drive or use machines.


3. How to use Salmeterol/Fluticasone Cipla


Always use this medicine exactly as your doctor or pharmacist has told you. Don’t exceed the recommended dose.Check with your doctor or pharmacist if you are not sure.


Adults and adolescents aged 12 years and over


Use in children and adolescents


Salmeterol/Fluticasone Cipla 125 mcg/25mcg and 250 mcg/25mcg

is not recommended for use in children below 12 years of age.


The dose should be titrated to the lowest dose at which effective control of symptoms is maintained.


Where the control of symptoms is maintained with the lowest strength of Salmeterol/Fluticasone Cipla(25/125 microgram), the next step could include a switch to a different inhaled salmeterol fluticasone product available in a lower strength (25/50 micrograms).


It is very important to follow your doctor’s instructions onhow many inhalations to take and how often to take your medicine.


If you are using Salmeterol/Fluticasone Cipla for asthma, your doctor will want to regularly check your symptoms.


If your asthma or breathing gets worse, tell your doctor straight away. You may find that you feel more wheezy, your chest feels tight more often or you may need to use more of your fast acting ‘reliever’ medicine. If any of these happen, you should continue to take Salmeterol/Fluticasone Cipla but do not increase the number of puffs you take. Your chest condition may be getting worse and you could become seriously ill. See your doctor as you may need additional treatment.


Instructions for use

Your doctor, nurse or pharmacist should show you how to use your inhaler. They should check how you use it from time to time. Not using the Salmeterol/Fluticasone Cipla properly or asprescribed may mean that it will not help your asthma as it should.

The medicine is contained in a pressurised canister in a plastic casing with a mouthpiece.

There is an indicator in front of the Inhaler which tells you how many doses are left. As you use the inhaler the dose indicator will typically rotate during every five to seven puffs towards next decreasing number. The dose indicator will show the approximate no of puffs remaining in the inhaler

Take care not to drop the Inhaler as this may cause the indicator to count down.


Testing your Inhaler


1. When using the Inhaler for the first time, test that it is working. Remove the mouthpiece cover by gently squeezing the sides with your thumb and forefinger and pull apart.


2. To make sure that it works, shake it well, point the mouthpiece away from you and press the canister to release four puffs into the air. The dose indicator will show the number ‘120’ indicating the number of puffs in the inhaler. If you have not used your inhaler for a week or more, shake well and release two puffs of medicine into the air.

Using your Inhaler

It is important to start to breathe as slowly as possible just before using inhaler.


Stand or sit upright when using your inhaler.

Remove the mouthpiece cover. Check inside and outside to make sure that the mouthpiece is

clean and free of objects (figure A).



Shake the inhaler for 4 or 5 times to ensure that any loose objects are removed and that the

contents of the inhaler are evenly mixed (figure B).


Hold the inhaler upright with your thumb on the base, below the mouthpiece. Breathe out as far

as is comfortable (figure C).

Place the mouthpiece in your mouth between your teeth. Close your lips around it. Do not bite (figure D).

Breathe in through your mouth. Just after starting to breathe in, press down on the top of the

canister to release a puff of medicine. Do this while still breathing in steadily and deeply (figure D).

Hold your breathe, take the inhaler from your mouth and your finger from the top of the

inhaler. Continue holding your breathe for a few seconds, or as long as is comfortable (figure E).

Wait about half a minute between taking each puff of medicine and then repeat steps 3 to 7.

Afterwards, rinse your mouth with water and spit it out. This may help to stop you getting

thrush and being hoarse.

10. After use always replace the mouthpiece cover straight away to keep out dust. When the mouthpiece cover is fitted correctly it will ‘click’ into position. If it does not ‘click’ into place, turn the mouthpiece cover the other way round and try again. Do not use too much force.


If you find it difficult to use the inhaler, aspacer device may be used such as the Volumatic or AeroChamber Plus or other spacer devices (depending on National Guidance ). Before starting to use a spacer device for the first time or if you need to change your make of spacer device, talk to your doctor, nurse or pharmacist.

You should get a replacement when the indicator shows the number ‘40’ and the color on the dose indicator will change from green to red. Stop using the Inhaler when the indicator shows ‘0’ as any puffs left in the device may not be enough to give you a full dose. Never try to alter the numbers on the indicator or detach the indicator from the actuator. The indicator cannot be reset and is permanently attached to the actuator.


Cleaning your Inhaler

To stop your inhaler blocking, it is important to clean it at least once a week.

To clean your inhaler:

Wipe the inside and outside of the mouthpiece and the plastic casing with a dry cloth or

tissue.

Replace the mouthpiece cover. It will ‘click’ into place when fitted correctly. If it does not

‘click’ into place, turn the mouthpiece cover the other way round and try again. Do not use

too much force.


Do not put the metal canister in water.


If you use more Salmeterol/Fluticasone Cipla than you should

It is important to use the inhaler as instructed. If you accidentally take a larger dose than

recommended, talk to your doctor or pharmacist. You may notice your heart beating faster

than usual and that you feel shaky. You may also have a headache, muscle weakness and

aching joints.


If you have used larger doses for a long period of time, you should talk to your doctor or

pharmacist for advice. This is because larger doses of Salmeterol/Fluticasone Cipla may reduce the amount of steroid hormones produced by the adrenal gland.


If you forget to use Salmeterol/Fluticasone Cipla

If you forget to use your inhaler, take your next dose when it is due. Do not take a double dose to replace the one you forgot.


If you stop using Salmeterol/Fluticasone Cipla

It is very important that you take your Salmeterol/Fluticasone Cipla every day as directed. Keep taking it until yourdoctor tells you to stop. Do not stop or suddenly reduce your dose of Salmeterol/Fluticasone Cipla . This could makeyour breathing problem worse and very rarely side effects could occur.


These include:

Very rarely, if you get an infection or at times of extreme stress (such as after a serious accident or if you have surgery), you may get similar side effects.


To prevent these symptoms occurring, your doctor may prescribe extra corticosteroids (like

prednisolone).

If you have any further questions on using your Inhaler, ask your doctor or pharmacist.


4. Possible side effects


Like all medicines, this medicine can cause side effects, although not everybody gets them. To reduce the chance of side effects, your doctor will prescribe the lowest dose of Salmeterol/Fluticasone Cipla to control your asthma.


Allergic reactions: you may notice your breathing suddenly gets worse after using Salmeterol/Fluticasone Cipla .You may be very wheezy and cough. You may also notice itching and swelling (usually of the face, lips, tongue or throat). If you get these effects or if they happensuddenly after using Salmeterol/Fluticasone Cipla tell your doctor straight away. Allergic reactions toSalmeterol/Fluticasone Cipla are uncommon (they affect less than 1 person in 100).


Other side effects are listed below:

Very Common (affects more than 1 person in 10)


Common (affects less than 1 person in 10)


The following side effects have also been reported in patients with Chronic Obstructive Pulmonary Disease (COPD):

Pneumonia (infection of the lung) in COPD patients.

Tell your doctor if you have any of the following while taking Salmeterol/Fluticasone Cipla they could be symptoms of a lung infection:


Uncommon (affects less than 1 person in 100)


Rare (affects less than 1 person in 1000)


Breathing difficulties or wheezing that get worse straight after taking Salmeterol/Fluticasone Cipla. If this happens stop using your Salmeterol/Fluticasone Cipla. Use your fast-acting ‘reliever’ Inhaler to help your breathing and tell your doctor straight away.


Salmeterol/Fluticasone Cipla may affect the normal production of steroid hormones in the body, particularly if you have taken high doses for long periods of time. The effects include:

Your doctor will check you regularly for any of these side effects and make sure you are

taking the lowest dose of Salmeterol/Fluticasone Cipla to control your asthma.



Frequency not known, but may also occur:

Depression or aggression. These effects are more like to occur in children. If any of the side effects become serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.


Reporting of side effects:

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can report the side effects directly via the national reporting system listed in Appendix V*. By reporting side effects you can help provide more information on the safety of this medicine.


5. How to store Salmeterol/Fluticasone Cipla


excessive force.

The metal canister contains a pressurised liquid. Do not pierce the canister.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.


6. Contents of the pack and other information


What Salmeterol/Fluticasone Cipla contains

Each metered dose of Salmeterol/Fluticasone Ciplaprovides:

25 micrograms of salmeterol (as salmeterol xinafoate) and 125 or 250 micrograms of fluticasone propionate (delivered from the valve). This is equivalent to 21 micrograms of salmeterol and 110 or 220 micrograms of fluticasone propionate delivered from the actuator (delivered dose).

The other ingredient is norflurane (HFA 134a).


What Salmeterol/Fluticasone Cipla looks like and contents of the pack



Pack sizes:

1, 2 (bundled package 2x1) or 3 (bundled package 3x1) canisters containing 120 doses.

10 (bundled package 10x1) canisters containing 120 doses -hospital/pharmacy use only


Not all pack sizes may be marketed.


Marketing Authorisation Holder and Manufacturer


Marketing Authorisation Holder

Cipla Europe NV

Uitbreidingstraat 80,

2600 Antwerp,

Belgium


Manufacturer

S&D Pharma CZ, spol. s r.o,

Theodor 28, 273 08

Pchery (Pharmos a.s. facility),

Ceská Republika.


Cipla (EU) Ltd,

20 Balderton Street,

London W1K 6TL,

United Kingdom


Cipla Europe NV

Uitbreidingstraat 80,

2600 Antwerp,

Belgium


This medicinal product is authorised in the Member States of the EEA under the following names:

Sweden



Salmeterol/Fluticasone Cipla 25 mikrogram/125 mikrogram/dos inhalationsspray, suspension

Salmeterol/Fluticasone Cipla 25 mikrogram/250 mikrogram/dos inhalationsspray, suspension


Germany

SERROFLO 25 Mikrogramm/125 Mikrogramm/Dosis Druckgasinhalation, Suspension

SERROFLO 25 Mikrogramm/250 Mikrogramm/Dosis Druckgasinhalation, Suspension


Czech Republic

FULLHALE 25 mikrogramů/125mikrogramů/dávka Suspenze k inhalaci v tlakovém obalu

FULLHALE 25 mikrogramů/250 mikrogramů/dávka Suspenze k inhalaci v tlakovém obalu

Island

Salmeterol Fluticasone Cipla 25/125 míkróg/skammt Innúðalyf, dreifa

Salmeterol Fluticasone Cipla 25/250 míkróg/skammt Innúðalyf, dreifa

Luxumburg

SERROFLO 25/125 microgrammes per dose suspension pour inhalation en flacon pressurise

SERROFLO 25/250 microgrammes per dose suspension pour inhalation en flacon pressurise


Slovak

FULLHALE 25 mikrogramov/125 mikrogramov/dávka inhalačná suspenzia v tlakovom obale

FULLHALE 25 mikrogramov/250 mikrogramov/dávka inhalačná suspenzia v tlakovom obale

Greece


CIPLACOMBO 25/125 μικρογραμμάρια ανά δόση εναιώρημα για εισπνοή υπό πίεση

CIPLACOMBO 25/250 μικρογραμμάρια ανά δόση εναιώρημα για εισπνοή υπό πίεση


This leaflet was last revised in 4 November 2016